Cancer researchers have spent decades cataloging mutations found in tumors, building databases that now hold millions of ...

Tests with rodents suggest an mRNA vaccine in development offers protection against three strains of Ebola virus, including ...

Genes undergo extensive editing through a process called alternative splicing, which greatly increases the size of the ...

Clinical Supply Agreement to support phase II clinical trial: Cambridge, UK Friday, May 22, 2026, 18:00 Hrs [IST] 4basebio PLC, a company pioneering an enzymatically ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the ...

Not all broken genes fail in the same way: some simply stop working, while others interfere with what still works.

Living systems such as cells rely on membrane pores and channels to transport molecules, exchange signals, and organize biochemical reactions. These functions emerge from dynamic interactions between ...

Engage Biologics has developed a novel DNA delivery system, called Tethosome, which it says will speed the development of non-viral genetic medicines at Lilly.

Engage Biologics is developing the Tethosome platform, a non-viral DNA delivery system. ・Engage said its platform addresses major challenges such as immune sensing and efficient cellular delivery.

A new @HopkinsMedicine study of mice reveals that epigenetic marks can be inherited in ways that break the century-long ...

Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is ...